Ushanti Colour Chem Limited (NSE:UCL)

ASLAN Pharmaceuticals Statistics

Total Valuation

NSE:UCL has a market cap or net worth of INR 535.09 million. The enterprise value is 1.05 billion.

Market Cap	535.09M
Enterprise Value	1.05B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:UCL has 10.70 million shares outstanding. The number of shares has increased by 3.51% in one year.

Current Share Class	10.70M
Shares Outstanding	10.70M
Shares Change (YoY)	+3.51%
Shares Change (QoQ)	-89.41%
Owned by Insiders (%)	54.86%
Owned by Institutions (%)	n/a
Float	3.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.69
PB Ratio	1.34
P/TBV Ratio	1.21
P/FCF Ratio	29.17
P/OCF Ratio	10.54
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.09, with an EV/FCF ratio of 57.29.

EV / Earnings	-39.81
EV / Sales	1.35
EV / EBITDA	62.09
EV / EBIT	n/a
EV / FCF	57.29

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 1.42.

Current Ratio	0.75
Quick Ratio	0.24
Debt / Equity	1.42
Debt / EBITDA	33.50
Debt / FCF	30.91
Interest Coverage	-0.45

Financial Efficiency

Return on equity (ROE) is -16.70% and return on invested capital (ROIC) is -1.54%.

Return on Equity (ROE)	-16.70%
Return on Assets (ROA)	-1.30%
Return on Invested Capital (ROIC)	-1.54%
Return on Capital Employed (ROCE)	-3.74%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	126
Asset Turnover	0.68
Inventory Turnover	5.05

Taxes

In the past 12 months, NSE:UCL has paid 8.57 million in taxes.

Income Tax	8.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.89% in the last 52 weeks. The beta is 0.86, so NSE:UCL's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-11.89%
50-Day Moving Average	56.36
200-Day Moving Average	60.06
Relative Strength Index (RSI)	46.86
Average Volume (20 Days)	19,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:UCL had revenue of INR 780.50 million and -26.40 million in losses. Loss per share was -2.43.

Revenue	780.50M
Gross Profit	72.72M
Operating Income	-23.71M
Pretax Income	-61.56M
Net Income	-26.40M
EBITDA	16.93M
EBIT	-23.71M
Loss Per Share	-2.43

Balance Sheet

The company has 5.14 million in cash and 566.95 million in debt, giving a net cash position of -561.81 million or -52.50 per share.

Cash & Cash Equivalents	5.14M
Total Debt	566.95M
Net Cash	-561.81M
Net Cash Per Share	-52.50
Equity (Book Value)	399.02M
Book Value Per Share	40.95
Working Capital	-142.34M

Cash Flow

In the last 12 months, operating cash flow was 50.79 million and capital expenditures -32.44 million, giving a free cash flow of 18.34 million.

Operating Cash Flow	50.79M
Capital Expenditures	-32.44M
Free Cash Flow	18.34M
FCF Per Share	1.71

Margins

Gross margin is 9.32%, with operating and profit margins of -3.04% and -3.38%.

Gross Margin	9.32%
Operating Margin	-3.04%
Pretax Margin	-7.89%
Profit Margin	-3.38%
EBITDA Margin	2.17%
EBIT Margin	-3.04%
FCF Margin	2.35%

Dividends & Yields

NSE:UCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.51%
Shareholder Yield	n/a
Earnings Yield	-4.93%
FCF Yield	3.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4